Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Nasopharyngeal Carcinoma 11 Squamous Cell Carcinoma of Head and Neck 9 Small Cell Lung Carcinoma 9 Uterine Cervical Neoplasms 7 Cholangiocarcinoma 6 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Neoplasms 3 Endometrial Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Triple Negative Breast Neoplasms 1 Tongue Squamous Cell Carcinoma 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Solid Tumor Cancer 1 Recurrence 1 Rare Tumour 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

pembrolizumab 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 Specimen Handling 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Hematologic Tests 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Merkel Cell × Cisplatin × Clear all

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡